Case Study
Understanding why Novavax selected IDBS PIMS as their process information management system
Novavax, a biotechnology company focused on developing innovative vaccines for serious infectious diseases, selected IDBS PIMS as its process information management system to support the development and commercialization of its vaccine portfolio. With extensive experience addressing diseases such as influenza, RSV, Ebola, MERS, SARS, and COVID-19, the company required a robust platform to manage the growing complexity of process and manufacturing data as programs advanced toward late-stage clinical development and commercialization. IDBS PIMS provided a centralized environment for collecting, organizing, and analyzing process information across development and manufacturing activities. The platform improved data visibility, collaboration, traceability, and decision-making while supporting
